Hierarchical Autophagy Substrate Restoration as a Strategy to Reverse Immunosenescence

Hypothesis

Aging immune cells lose the ordered sequence in which autophagy receptors select cargo, shifting from targeted clearance of inflammasome components, damaged mitochondria, and protein aggregates to indiscriminate bulk degradation. Restoring the youthful priority order—p62→NLRP3, NDP52→mitochondria, OPTN→aggregates—by modulating receptor phosphorylation states will reduce inflammaging and restore hematopoietic stem cell (HSC) function more effectively than increasing total autophagic flux.

Mechanistic Basis

Selective autophagy relies on a hierarchy encoded by post‑translational modifications of receptors such as p62, NDP52, and OPTN. In young cells, ULK1‑dependent priming primes high‑affinity ubiquitin binding sites, while TBK1 phosphorylates secondary sites to lock cargo specificity. Age‑related TORC1‑S6K hyperactivity shifts the balance toward low‑efficiency phosphorylation, causing receptors to bind ubiquitin chains promiscuously and engage bulk autophagy. This loss of sequence allows NLRP3 inflammasome components to persist, mitochondrial damage to accumulate DAMPs, and lipofuscin‑like aggregates to build up, together driving SASP secretion. The hierarchy therefore acts as a checkpoint: upstream cargo must be cleared before downstream sensors can be activated; breaking the sequence creates a feed‑forward loop that further suppresses selectivity.

Testable Predictions

1. Pharmacological enhancement of p62‑S403 phosphorylation (or NDP52‑S25) in aged HSCs will increase clearance of NLRP3 and mitochondrial cargo without raising LC3‑II levels, leading to lowered IL‑1β and IL‑6 secretion.
2. Forcing bulk autophagy with rapamycin will elevate total flux but will not restore the p62→NLRP3→NDP52→OPTN order and will fail to improve HSC repopulation capacity.
3. Re‑establishing the receptor hierarchy will decrease SASP‑mediated inhibition of naïve T‑cell production and improve competitive transplantation outcomes in aged mice.

If these predictions fail—i.e., restoring receptor selectivity does not reduce inflammaging or enhance HSC function, or bulk autophagy alone rescues the phenotype—the hypothesis is falsified. Conversely, if bulk autophagy outperforms selective restoration, the hierarchy model requires revision.

Experimental Design

• Isolate HSCs from 20‑month‑old mice; treat ex vivo with a small‑molecule activator of ULK1 (to boost p62‑S403) or a TBK1‑mimetic peptide (to enhance NDP52‑S25). Verify receptor phosphorylation by western blot with phospho‑specific antibodies.
• Measure cargo degradation using mito‑Keima for mitochondria, NLRP3‑GFP puncta, and p62‑aggregate immunofluorescence; quantify LC3‑II to ensure total flux remains unchanged.
• Assess cytokine secretion (IL‑1β, IL‑6, TNF‑α) by ELISA.
• Perform competitive transplantation: mix treated aged HSCs with congenic young bone marrow and track chimerism over 16 weeks.
• Control groups: vehicle, rapamycin (bulk autophagy inducer), and a non‑phosphorylatable receptor mutant.

Expected Outcome

Selective receptor activation will normalize the autophagy cargo sequence, lower inflammasome activity, improve mitochondrial quality, and restore HSC regenerative capacity without altering overall autophagic rate. This would support the view that the order of substrate consumption—not just the act of self‑eating—is a critical determinant of immune aging.